Novel 4(3H)-quinazolinone analogs: synthesis and anticonvulsant activity
A new series of quinazoline analogs was designed, synthesized, and evaluated for their anticonvulsant activity. Compounds 6 , 12 , 21 , 36 , 37 , and 38 showed 70–100 % protection against PTZ-induced seizures acting as GABA A receptor agonists. Compound N -(3,4,5,6-tetrachloro-phthalimido)-2-[(3-phe...
Saved in:
Published in | Medicinal chemistry research Vol. 22; no. 6; pp. 2815 - 2827 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer-Verlag
01.06.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A new series of quinazoline analogs was designed, synthesized, and evaluated for their anticonvulsant activity. Compounds
6
,
12
,
21
,
36
,
37
, and
38
showed 70–100 % protection against PTZ-induced seizures acting as GABA
A
receptor agonists. Compound
N
-(3,4,5,6-tetrachloro-phthalimido)-2-[(3-phenyl-4-oxo-6-methyl-3
H
-quinazolin-2-yl)-thio]acetamide (
12
) representing the moderate active compounds and 2-[6-iodo-4-oxo-2-(thiophen-2-yl)-quinazolin-3(4
H
)-yl]-isoindoline-1,3-dione (
38
) representing the remarkably active compounds in this stud, showed ED
50
values of 457 and 251 mg/kg; TD
50
values of 562 and 447 mg/kg; PI values of 1.22 and 1.78, LD
50
values of 1,288 and 1,380 mg/kg, and TI values of 2.82 and 5.50, respectively. Compound
38
proved to be almost twofold more active than the standard drug sodium valproate. |
---|---|
ISSN: | 1054-2523 1554-8120 |
DOI: | 10.1007/s00044-012-0280-y |